Literature DB >> 9430519

Light microscopic changes in Plasmodium falciparum from Gabonese children treated with artemether.

M Kombila1, T H Duong, D Dufillot, J Koko, V Guiyedi, C Guiguen, A Ferrer, D Richard-Lenoble.   

Abstract

The changes in Plasmodium falciparum in four Gabonese children suffering from severe malaria and treated with pure artemether were observed in thin blood smears fixed and stained with Giemsa and examined by light microscopy. Peripheral blood samples were taken every 8 hr up to 72 hr from three children and every 3 hr up to 9 hr from the other child. The morphologic changes involved all development stages (trophozoites, schizonts, and gametocytes); they were first seen 3 hr after the start of treatment and all parasites were abnormal after 24 hr. After two days of treatment, all infected erythrocytes disappeared except for a few with necrotic trophozoites. The morphologic changes were similar to the ultrastructural changes previously described in vivo and in vitro in experimental models. They confirm the rapid effect of artemisinin derivatives on parasite clearance and clinical recovery, particularly in cases of cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430519     DOI: 10.4269/ajtmh.1997.57.643

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins.

Authors:  Delphine Cardi; Alexandre Pozza; Bertrand Arnou; Estelle Marchal; Johannes D Clausen; Jens Peter Andersen; Sanjeev Krishna; Jesper V Møller; Marc le Maire; Christine Jaxel
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.